Whilst HIF-1α expression has been consistently associated with disease progression and worse prognosis in breast cancer [10, 20, 61–63], the prognostic implications of HIF-2α expression have remained unclear [64, 65]. This evidence concerns the gene HIF1A and breast carcinoma.